Abstract:Our findings provide an efficient combination strategy for increasing clinically important daptomycin production by enhancing aspartate precursor supply, abolishing by‐product red pigment production, engineering daptomycin biosynthetic gene cluster (BGC) by promoter replacement, and duplicating the engineered daptomycin BGC in Streptomyces roseosporus wild‐type strain. We finally obtained a maximal DAP titre of 350.7 μg/mL, representing the highest reported titre in shake‐flask fermentation. Such strategies can be readily applied in the overproduction of other antibiotics using aspartate as a precursor. Daptomycin (DAP), a novel cyclic lipopeptide antibiotic produced by Streptomyces roseosporus, is clinically important for treatment of infections caused by multidrug‐resistant Gram‐positive pathogens, but the low yield hampers its large‐scale industrial production. Here, we describe a combination metabolic engineering strategy for constructing a DAP high‐yielding strain. Initially, we enhanced aspartate (Asp) precursor supply in S. roseosporus wild‐type (WT) strain by separately inhibiting Asp degradation and competitive pathway genes using CRISPRi and overexpressing Asp synthetic pathway genes using strong promoter kasOp*. The resulting strains all showed increased DAP titre. Combined inhibition of acsA4, pta, pyrB, and pyrC increased DAP titre to 167.4 μg/mL (73.5% higher than WT value). Co‐overexpression of aspC, gdhA, ppc, and ecaA led to DAP titre 168 μg/mL (75.7% higher than WT value). Concurrently, we constructed a chassis strain favourable for DAP production by abolishing by‐product production (i.e., deleting a 21.1 kb region of the red pigment biosynthetic gene cluster (BGC)) and engineering the DAP BGC (i.e., replacing its native dptEp with kasOp*). Titre for the resulting chassis strain reached 185.8 μg/mL. Application of our Asp precursor supply strategies to the chassis strain further increased DAP titre to 302 μg/mL (2.1‐fold higher than WT value). Subsequently, we cloned the engineered DAP BGC and duplicated it in the chassis strain, leading to DAP titre 274.6 μg/mL. The above strategies, in combination, resulted in maximal DAP titre 350.7 μg/mL (2.6‐fold higher than WT value), representing the highest reported DAP titre in shake‐flask fermentation. These findings provide an efficient combination strategy for increasing DAP production and can also be readily applied in the overproduction of other Asp‐related antibiotics.

Large-scale Synthesis of Dihydrostreptomycin Via Hydrogenation of Streptomycin in a Membrane Dispersion Microreactor

Improving the Yield and Quality of Daptomycin in Streptomyces Roseosporus by Multilevel Metabolic Engineering

Scaling Up Microreactors for Kilogram‐scale Synthesis of Piperacillin: Experiments and Computational Fluid Dynamics Simulations

High-yield gram-scale organic synthesis using accelerated microdroplet/thin film reactions with solvent recycling

Mass spectrometric directed system for the continuous-flow synthesis and purification of diphenhydramine

A Method for Improving Microbial Conversion of Diosgenin and Separation and Identification of the Product

Practical Synthesis from Streptomycin and Regioselective Partial Deprotections of (-)-(1 R ,2 S ,3 R ,4 R ,5 S ,6 S )-1,3-Di(deamino)-1,3-diazido-2,5,6-tri- O -benzylstreptamine

Development of a Continuous Flow Process for the Efficient Preparation of Anti-Tuberculosis-Specific Drug TBAJ-876

Continuous-Flow Synthesis of Methyl Sulfone with Microchannel Reactors: A Safer and Efficient Production Strategy

Effect and regeneration of heterogeneous palladium/charcoal catalysts poisoned by tetramethylthiourea–quinoline in the stereoselective hydrogenation of methacycline to α-doxycycline

Harnessing the intracellular triacylglycerols for titer improvement of polyketides in Streptomyces

Methoxylation of Dihydromyrcene in an Intensified Fixed Bed Reactor

Enhancement of ascomycin production in Streptomyces hygroscopicus var. ascomyceticus by combining resin HP20 addition and metabolic profiling analysis

Metabolic engineering of Streptomyces roseosporus for increased production of clinically important antibiotic daptomycin

Reduction of Foaming and Enhancement of Ascomycin Production in Rational Streptomyces Hygroscopicus Fermentation

Constructing a continuous-flow bioreactor with co-immobilized KmAKR and BmGDH for synthesizing tert-butyl 6-cyano-(3R,5R)-dihydroxyhexanoate

In silico aided metabolic engineering of Streptomyces roseosporus for daptomycin yield improvement

Design and Optimization of a Continuous Stirred Tank Reactor Cascade for Membrane-Based Diazomethane Production: Synthesis of α-Chloroketones

[Determination of Streptomycin and Dihydrostreptomycin in Pollens by High Performance Liquid Chromatography-Tandem Mass Spectrometry].

Mechanically stirred enzymatic membrane reactor containing HRP immobilized on Tau-SiO2@Fe3O4-GO nanocomposite for removal of tetracycline in synthetically concocted wastewater

Process Intensification Of Catalytic Hydrogenation Of Ethylanthraquinone With Gas-Liquid Microdispersion